Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy - Wikidata - wikimedia - TriplyDB

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

http://www.wikidata.org/entity/Q27316185

about

Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review NMR Meets Tau: Insights into Its Function and Pathology New Features about Tau Function and Dysfunction Traumatic Axonal Injury: Mechanisms and Translational Opportunities Function and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegeneration Towards Personalized Intervention for Alzheimer's Disease Chronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau Oligomers Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation.Considerations for Experimental Animal Models of Concussion, Traumatic Brain Injury, and Chronic Traumatic Encephalopathy-These Matters Matter.Mapping the Connectome Following Traumatic Brain Injury.Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy.The Expression of NP847 and Sox2 after TBI and Its Influence on NSCs.Neuroinflammation in animal models of traumatic brain injury.Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation.Sports-related concussions - media, science and policy.MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.Neurodegenerative disease in 2015: Targeting tauopathies for therapeutic translation Memantine improves outcomes after repetitive traumatic brain injury.Microstructural and microglial changes after repetitive mild traumatic brain injury in mice.The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.Environmental Enrichment Mitigates Deficits after Repetitive Mild Traumatic Brain Injury.The role of Pin1 in the development and treatment of cancer.Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy.Neighboring phosphoSer-Pro motifs in the undefined domain of IRAK1 impart bivalent advantage for Pin1 binding.A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.Prion-like Spreading in Tauopathies.Noncontact Rotational Head Injury Produces Transient Cognitive Deficits but Lasting Neuropathological Changes.Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach Signature of an aggregation-prone conformation of tau.Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae.The Biological Basis of Chronic Traumatic Encephalopathy following Blast Injury: A Literature Review.ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

P2860

Q26744281-FB305DE9-64CA-454C-9FF7-562809EE8846 Q26747418-4F88B9EC-E363-46DC-A180-94C331853713 Q26750922-FBC6A4DD-9ACE-4BC2-82A7-3C8210C86FCC Q26753059-4086D58B-89CF-4E6B-BA6D-88F622BD6EEB Q28080073-12D51B87-6EE5-488C-A8CF-827442D83772 Q28080098-F5B6A3B0-F9D9-4E19-805E-1E29C9EB5699 Q28397264-89B3A3D7-E65A-487E-8FEA-A2449F1799C8 Q30805841-D5C0E727-2FE4-434D-BE8F-649CFF1B717C Q33714909-CB9D7C39-150E-4CD2-83DD-7B0AA7CD9FCA Q33747407-89EB707C-49D8-4842-914A-40C842E858EE Q35972236-B6C8C619-DBEC-4AB1-ADF3-B8D0746CC7C9 Q35972860-204DE417-FB4A-4554-A821-D69D200A6C7C Q36206627-4174F581-5284-425A-929A-2C8068D6A286 Q36803316-EFE6A0D3-98AF-4291-BA06-76E66FA8358E Q37374408-B5B2E50F-494F-4A18-BC11-A8D8A84B1D04 Q37525476-85AF4076-8D4D-4822-84CA-7632DCC31DE3 Q37546147-0C945728-E612-406F-88F5-3AFB64807F46 Q37598940-75B1D81F-6382-4A88-BCF0-3F88C3D3D4AE Q37676914-10B7F17C-EFAE-4694-8CC9-BD1BD9D3BBF2 Q37739814-CC5CF18E-3B56-4A67-95C9-85920077123B Q38451090-0410EA33-582F-47EF-B424-6B8CDFE8FCC1 Q38652516-8CDA85CD-6CBA-414C-9425-AB889A1366AA Q38666247-F282D843-5F0F-437A-A195-D11462B11CC1 Q38705770-D8BF33DA-896F-4738-817A-E50C4B4F85E4 Q38835597-C0E27C75-4400-4EC5-B102-5E21F1DE9F0F Q38838386-3F1433F5-265C-4E0D-97E4-879E9520830A Q38852028-17C9A01E-3DBB-484F-92A0-4AD5DE66A8A0 Q38855306-B536C0DA-DA6A-4289-B6CA-24E566E0B5FD Q38939954-8707BC47-D802-4D24-B89C-4FDC43636F8F Q38998886-C0117FE3-B909-4CE7-A7A8-5DB5C9D01C86 Q39149587-22CC3EAB-2E2F-474A-AD94-3D754CCF252A Q39240086-227ACA7A-F110-42E5-BF09-765715771050 Q39270980-5DECD0BA-0929-4573-8152-9EBF06A80AA3 Q39307688-3EBF4C73-6F8F-482A-B4E0-75EABC8AFE58 Q40134768-3534620D-8D60-4EFE-B75D-BD7E51C212B9 Q41629521-487AED6C-4190-44F9-8F69-48EAE550409D Q41900247-EB25BE0F-C9F1-407E-A1E7-DC101BBF08EC Q42379648-3E557C25-45C1-4091-98F1-2E8F056A85E3 Q45068024-F445AD8E-54B0-4C20-B02C-778538A704EA Q46180253-83E594D9-2AC4-4427-9E32-91F5F579BEEE

P2860

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

http://www.wikidata.org/entity/Q27316185

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Antibody against early driver ...... cks brain injury and tauopathy

@ast

Antibody against early driver ...... cks brain injury and tauopathy

@en

Antibody against early driver ...... cks brain injury and tauopathy

@nl

type

label

Antibody against early driver ...... cks brain injury and tauopathy

@ast

Antibody against early driver ...... cks brain injury and tauopathy

@en

Antibody against early driver ...... cks brain injury and tauopathy

@nl

prefLabel

Antibody against early driver ...... cks brain injury and tauopathy

@ast

Antibody against early driver ...... cks brain injury and tauopathy

@en

Antibody against early driver ...... cks brain injury and tauopathy

@nl

P1433

Q27316185-4EF519A0-5337-406F-886F-EB329630C790

P1476

Q27316185-5233F498-3A72-49AF-BFE8-17812A91FA95

P2093

Q27316185-059195F4-D8E9-4989-9566-940803CE25D4

Q27316185-05C9500C-DC66-4A03-BDE1-844FC7179609

Q27316185-0EFA4DFB-7773-43BD-99EE-48D42BE70F04

Q27316185-1DFAE9F1-FCF2-4B4A-89A6-F295F46E5D8D

Q27316185-2A8F3EE1-BB2D-44EF-B09D-FE0DFF8BCD08

Q27316185-2B74D26A-72D5-495F-A18B-1FB03566EBBB

Q27316185-32ADB7A0-A6D6-4919-A978-D1B952F8D15D

Q27316185-3CC6E41C-E217-49D2-B195-A6121F89E2F0

Q27316185-4E96A81F-0F71-4EF9-820E-1EEE9DED4E49

Q27316185-510A45ED-0919-4260-BB9B-CB75A2E8A795

P2860

Q27316185-010CAFFA-A513-4722-A791-D8398F398982

Q27316185-0B52BAD3-D754-496E-939D-1D271B97BE14

Q27316185-111B72B9-BD11-4405-9440-5E7D67AA4649

Q27316185-14EEBFF0-AF99-422F-B219-EB9AF5883312

Q27316185-15C08B86-5D4C-4133-AE98-F6FF126FED20

Q27316185-16C62944-0B55-4C3C-AFAA-E769ADC25685

Q27316185-194FDE66-6897-4E2F-B6C4-F67B4478A4B7

Q27316185-1C66CFCD-663B-40BA-9A96-4E111BDDAE55

Q27316185-1CB08F43-326D-4E71-916B-151AE28DCA47

Q27316185-1EFDCD20-A7CC-4D4E-8E63-842B7BCC5B92

P2888

Q27316185-AD927F1C-23BD-4A73-81FB-CF33EF4EA264

P304

Q27316185-2D476E23-39DD-4CF9-9BA4-9C792C59B4F2

P31

Q27316185-0DCF2953-FFDC-439D-B8CF-6591A4D97B38

P3181

Q27316185-CA865CA5-FF1D-4D05-B618-E56B213EA2B7

P356

Q27316185-6332A240-F3D8-4907-BC4E-F7FEF342E3A1

P407

Q27316185-AB1A3EC5-86E5-4BB4-BAB2-5EE4D36B72D6

P433

Q27316185-61DFCD1D-7B0B-44F1-ADFB-CA51E15DD639

P478

Q27316185-0EDD9D9C-7FDB-421B-B1B9-97FFDB4CC0BA

P50

Q27316185-2F42590D-1E02-4B0F-AFEF-314A7BA29857

Q27316185-818A8583-C7BE-4835-8FC0-FE9CEA71E891

P577

Q27316185-1365C216-37BE-4C49-AC46-E89B3911A958

P6179

Q27316185-CA81045F-2F25-41FF-99A2-25E55B0AD35E

P698

Q27316185-9E4F4C62-8AC9-4E9C-B07D-829247D5144F

P921

Q27316185-1F183342-689B-4157-9B7C-FA766FF16BDA

Q27316185-51D92C07-56E6-4C25-9DFD-08DB042927E4

P932

Q27316185-122C91C3-BCB4-48EB-9F29-657DBBE5CE55

P3181

P356

P1433

P1476

Antibody against early driver ...... cks brain injury and tauopathy

@en

P2093

Akihide Ryo

http://www.w3.org/2001/XMLSchema#string

Alexander Rotenberg

http://www.w3.org/2001/XMLSchema#string

Ann C McKee

http://www.w3.org/2001/XMLSchema#string

Asami Kondo

http://www.w3.org/2001/XMLSchema#string

Chun-Hau Chen

http://www.w3.org/2001/XMLSchema#string

Jane A Driver

http://www.w3.org/2001/XMLSchema#string

Jianhua Qiu

http://www.w3.org/2001/XMLSchema#string

Koorosh Shahpasand

http://www.w3.org/2001/XMLSchema#string

Kun Ping Lu

http://www.w3.org/2001/XMLSchema#string

Lee E Goldstein

http://www.w3.org/2001/XMLSchema#string

P2860

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.

The spectrum of disease in chronic traumatic encephalopathy

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production

Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)

Transmission and spreading of tauopathy in transgenic mouse brain

Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers.

A human peptidyl-prolyl isomerase essential for regulation of mitosis

Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Trans-synaptic spread of tau pathology in vivo

P2888

P304

431-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

605035

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE14658

http://www.w3.org/2001/XMLSchema#string

P407

P433

7561

http://www.w3.org/2001/XMLSchema#string

P478

523

http://www.w3.org/2001/XMLSchema#string

P50

Juliet Moncaster

Alvaro Pascual-Leone

P577

2015-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053696664

http://www.w3.org/2001/XMLSchema#string

P698

26176913

http://www.w3.org/2001/XMLSchema#string

P921

P932

4718588

http://www.w3.org/2001/XMLSchema#string